About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker EXEL

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 3, 202612780819
Compounds and methods of use
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Nov 3, 202612778942
Processes for preparing quinoline compounds and pharmaceutical compos…
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Jul 14, 202612679893
PD-L1 binding agents and uses thereof
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Jul 14, 202612679809
Crystalline forms and salt forms of a kinase inhibitor
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Jul 7, 202612673052
Combinations for the treatment of cancer
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Dec 23, 202512503438
Compounds for the treatment of kinase-dependent disorders
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Dec 16, 202512497367
Processes for the preparation of a kinase inhibitor
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Dec 2, 202512486233
Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phen…
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Jul 29, 202512371428
Pyridone compounds and methods of use
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Apr 15, 202512275706
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′…
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Apr 1, 202512264161
Heterocyclic adenosine receptor antagonists
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Feb 18, 202512227481
Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl…
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Jan 14, 202512195475
Compounds for the treatment of kinase-dependent disorders
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗
Oct 29, 202412128039
Processes for preparing quinoline compounds and pharmaceutical compos…
EXEL
Exelixis, Inc.
utilityGoogle Patents ↗

14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:41 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances